Frank Hilberg,Marco Hans Hofmann,Markus Reschke,Flavio Solca
申请号：
US15995375
公开号：
US20180346559A1
申请日:
2018.06.01
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The invention relates to the combined use of certain bispecific, VEGF and Ang2 binding molecules with PD1 antagonists for the treatment of cancer. It further relates to pharmaceutical compositions and kits comprising such binding molecules and antagonists.
